NCT04124536

Brief Summary

The overall objective of this study is to evaluate whether the addition of secondary distribution HIV self-test kits to existing partner notification guidelines increases the proportion of male partners who access facility-based HIV testing services, when compared to the partner notification strategy alone

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
341

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 3, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 9, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 11, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 3, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2020

Completed
9 months until next milestone

Results Posted

Study results publicly available

May 24, 2021

Completed
Last Updated

July 21, 2021

Status Verified

April 1, 2021

Enrollment Period

10 months

First QC Date

October 9, 2019

Results QC Date

April 29, 2021

Last Update Submit

June 30, 2021

Conditions

Keywords

Self TestingPartner notificationSecondary Distribution

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Reported Primary Male Partner Completed HIV Testing at a Healthcare Facility

    The number of participants who report their primary male partners getting tested for HIV at a healthcare facility when presented with partner notification plus secondary distribution of HIV self-test kits compared to partner notification alone

    Enrollment - 30 days post enrollment of study participant

Secondary Outcomes (4)

  • Number of Participants Who Reported HIV Testing With Primary Male Partner at a Healthcare Facility

    Enrollment - 30 days post enrollment of study participant

  • Number of Participants Reporting Social Harms

    Enrollment - 30 days post enrollment of study participant

  • Number of Healthcare Providers Describing Feasibility of Intervention Via In-depth Interviews (Qualitative)

    6 months after the start of enrollment

  • Number of Participants Describing Acceptability of Intervention Via In-depth Interviews (Qualitative)

    In the first two months of enrollment

Other Outcomes (1)

  • Number of Participants Who Reported Primary Male Partner HIV Testing Completed at Any Venue

    Enrollment - 30 days post enrollment of study participant

Study Arms (2)

Intervention

EXPERIMENTAL

In addition to standard partner notification services, the intervention arm will receive HIV self-test kits and structured counseling about HIVST, regardless of HIV status.

Behavioral: HIV self-testing with partner notification.

Control

NO INTERVENTION

Standard partner notification services, regardless of HIV status.

Interventions

HIV self-test kits are oral swabs. Partner notification will be offered to all women in the intervention arm, regardless of HIV status.

Intervention

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years of age or older
  • Pregnant at time of enrollment based on antenatal record
  • Documented HIV status (either positive or negative) in antenatal record
  • Reports at least one current sexual partner
  • Willingness to provide her own contact information
  • Ability and willingness to provide informed consent
  • Intent to remain in current geographical area of residence for the duration of follow-up activities
  • Willingness to adhere to study procedures

You may not qualify if:

  • Women who express concerns about IPV or social harms as a result of participation during the screening process will not be included.
  • Women who have previously enrolled in the study will not be permitted to enroll again.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chipata Health Centre

Lusaka, Zambia

Location

Related Publications (1)

  • Mutale W, Freeborn K, Graybill LA, Lusaka MM, Mollan KR, Mweemba O, Kasaro M, Lungu R, Kumwenda A, Saidi F, Powers KA, Maman S, Rosenberg NE, Chi BH. Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials. Lancet Glob Health. 2021 Dec;9(12):e1719-e1729. doi: 10.1016/S2214-109X(21)00393-4. Epub 2021 Nov 1.

MeSH Terms

Interventions

Contact Tracing

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesPublic HealthEnvironment and Public HealthCommunicable Disease ControlPublic Health Practice

Results Point of Contact

Title
Benjamin Chi, MD, MSc
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Ben Chi, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2019

First Posted

October 11, 2019

Study Start

September 3, 2019

Primary Completion

July 3, 2020

Study Completion

September 7, 2020

Last Updated

July 21, 2021

Results First Posted

May 24, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Time Frame
9 to 36 months following publication
Access Criteria
IRB, IEC, or REB approval, as applicable, and an executed data use/sharing agreement with UNC.

Locations